Nanostics and OncoHelix Launch ClarityDX Prostate for Middle East Men at Risk of Aggressive Prostate Cancer

Nanostics Inc., a precision health company specializing in diagnostic tests through its ClarityDX® platform, has partnered with OncoHelix, a leader in precision diagnostics. Together, they will offer ClarityDX Prostate® to…

Read MoreNanostics and OncoHelix Launch ClarityDX Prostate for Middle East Men at Risk of Aggressive Prostate Cancer